In Vitro Fertilization (IVF) Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of In vitrfertilization Market

The in vitrfertilization market size was valued at USD 16.89 billion in 2018, and the market is now projected tgrow tUSD 65.63 billion by 2032, exhibiting a CAGR of 10.2% during the forecast period of 2019-2026.

COVID-19 has greatly affected the IVF market; primarily because of the restrictions on or even banning of non-emergency treatments, including IVF, as well as the redirection of healthcare resources. Most clinics either partially shut down, or significantly reduced their activity level, which translated intdeferred interventions and a lower rate of new clients. Also, matters concerning finance and mobility hobbled access tIVF services especially in regions where service import depended on such tourism. But the market is on the recovery path now as clinics opened up following the teleconsultation, other health-related technologies, and safety measures. The pandemic year alsenlightened the necessity of increasing the availability of procedures of fertility preservation, thus creating the demand for cryopreservation and similar technologies. This led tthe boost in in vitrfertilization market growth.

Some of the factors which are contributing tgrowth of the global IVF market are; growing incidence of infertility, improving success rate of IVF surgery and growing awareness about the condition. Furthermore, the development and implementation of new and better IVF service in terms of extended hills of IVF-recalling intracytoplasmic sperm injection (ICSI) is likely tfoster the growth of IVF market in the forecast period of 2019-2026. These factors drive the in vitrfertilization market share.

The uses of artificial intelligence and machine learning are rapidly being integrated intIVF treatments and are one of the current market trends. Patients’ medical histories, as well as embryimages, are run through the system tdetermine which is the best prognosis for implantation and develop the most effective treatment plan. It is enhancing the decisions made in clinic, minimizing the experiments and enhancing the cycles accomplished by IVF. In II, besides presenting several formulations for fertility treatment, AI-based tools are alsattracting the attention of clinics and patients globally due treduced costs and increased efficiency.

Comprehensive Analysis of In vitrfertilization Market

The in vitrfertilization market is responding quite an unprecedented rate of growth because of its market segmentation. This indicators growth in different regions by substituting the major forces of supply and demand which define the shape of local pharmacy benefit management market. Therefore, they are logically divided int3 Segments, By type outlook, By procedure outlook and By End-user Outlook. According ttypes, the market segments in IVF are conventional IVF, and IVF-ICSI. The market was largely held by IVF with ICSI segment in 2018 due tthe growth in the number of IVF-ICSI treatments globally. On the basis of procedure the global market is classified intfresh non-donor, frozen non-donor, fresh donor and frozen donor. The fresh non-donor segment is expected tattain a swift growth rate in the forecast period mainly because of the increasing incidence of infertility and increased chances of successfully implanting fresh eggs or embryos intthe uterus. In the view of the end users, global IVF market has been categorized intfertility clinics and hospitals category. It alswill be observed that the fertility clinics segment owned the largest market share in the entire distribution during the forecast period. This dominance is as a result of a growing number of patients seeking IVF procedures from fertility clinics, in addition twell trained staff offering precise care tthe patients.

The European region was valued at USD 7.57 billion in 2018 and dominated the market. The dominance is explained by growing incidence of infertility and steady improvement in the IVF treatment outcomes in the region. Some of the leading European countries on the choices of citizens for IVR treatment are Spain and Denmark.

Boston IVF (U.S.), Monash IVF (Australia), Pelargos IVF (Greece), Ovation Fertility (U.S.), RSMC (U.S.), Shady Grove Fertility (U.S.), Group Ambroise Paré Clinic (France), Bangkok IVF Center (Thailand), and Bloom IVF Centre (India) are significant players in the Healthcare market. They are the key player that ensures the industry's success while still having tkeep pace with their innovation in product and services. They offer a competitive zone that incites the growth of technologies and quality assurance. They operate on a global scale and have a wide range of product lines ensuring that the market players compete on a fair playing field bringing in innovations that result in the market's evolution.

In July 2019, Shady Grove Fertility revealed that it is set tlaunch its fung New full service IVF centre in Tampa Florida.

Segmentation Table

ATTRIBUTE DETAILS

Study Period - 2015-2026

Base Year - 2018

Forecast Period - 2019-2026

Historical Period - 2015-2017

Unit - Value (USD billion)

Segmentation By Type

• Conventional IVF
• IVF with ICSI

By Procedure

• Fresh Non-donor
• Frozen Non-donor
• Fresh Donor
• Frozen Donor

By End User

• Hospitals
• Fertility Clinics

By Geography

• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and the Rest of Latin America)
• Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)

Please Note: It will take 5-6 business days to complete the report upon order confirmation.